Product NDC: | 14539-150 |
Proprietary Name: | POLYETHYLENE GLYCOL 3350 |
Non Proprietary Name: | POLYETHYLENE GLYCOL 3350 |
Active Ingredient(s): | 17 g/1 & nbsp; POLYETHYLENE GLYCOL 3350 |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 14539-150 |
Labeler Name: | Emcure Pharmaceuticals USA Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202071 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110928 |
Package NDC: | 14539-150-20 |
Package Description: | 30 POWDER, FOR SOLUTION in 1 BOTTLE (14539-150-20) |
NDC Code | 14539-150-20 |
Proprietary Name | POLYETHYLENE GLYCOL 3350 |
Package Description | 30 POWDER, FOR SOLUTION in 1 BOTTLE (14539-150-20) |
Product NDC | 14539-150 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | POLYETHYLENE GLYCOL 3350 |
Dosage Form Name | POWDER, FOR SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20110928 |
Marketing Category Name | ANDA |
Labeler Name | Emcure Pharmaceuticals USA Inc. |
Substance Name | POLYETHYLENE GLYCOL 3350 |
Strength Number | 17 |
Strength Unit | g/1 |
Pharmaceutical Classes | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |